Considerations for the safe prescribing and use of COX‐2‐specific inhibitors
- 1 April 2002
- journal article
- position statement
- Published by AMPCo in The Medical Journal of Australia
- Vol. 176 (7) , 328-331
- https://doi.org/10.5694/j.1326-5377.2002.tb04434.x
Abstract
The majority of the “Australian COX‐2‐Specific Inhibitor (CSI) Prescribing Group” endorse the following points: CSIs are equivalent to non‐steroidal anti‐inflammatory drugs (NSAIDs) as anti‐inflamma...Keywords
This publication has 15 references indexed in Scilit:
- Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis PatientsClinical Journal of Sport Medicine, 2001
- Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt DietAnnals of Internal Medicine, 2000
- Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 InhibitorAmerican Journal of Gastroenterology, 2000
- Effects of Celecoxib and Naproxen on Renal Function in the ElderlyArchives of internal medicine (1960), 2000
- Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trialArthritis & Rheumatism, 2000
- Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.JAMA, 1999
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid ArthritisJAMA, 1999
- Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjectsClinical Pharmacology & Therapeutics, 1999